Customization: | Available |
---|---|
CAS No.: | 61012-19-9 |
Formula: | C59h84n16o12 |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | LECIRELIN |
CAS NO. | 61012-19-9 |
Molecular formula | C59H84N16O12 |
Molecular weight | 1209.42 |
Appearance | White Powder/ Freeze-Dried Powder |
Purity | >99% or customized |
Function:
The drug is intended for the induction of ovulation in cows, mares and rabbits, both for treatment of such conditions as ovarian cysts and for improvement of conception rates.
The recommended dosing regime is a single or repeated twice intramuscular treatment with 50-100 μg (cow, mare) or 0.5-0.8 μg (rabbit) of active compound.
1.Progestins | |||
1 | Progesterone | 57-83-0 | USP42;EP9.0 |
2 | Medroxyprogesterone Acetate | 71-58-9 | USP42;EP9.0 |
3 | Megestrol Acetate | 595-33-5 | USP42 |
4 | Altrenogest | 850-52-2 | In-house |
5 | Mifepristone | 84371-65-3 | CP2010 |
6 | Medroxyprogesterone Base | 520-85-4 | In-house |
7 | Megestrol | 3562-63-8 | In-house,99% |
8 | 17a-Hydroxyprogesterone caproate | 630-56-8 | USP42 |
9 | Allylestrenol | 432-60-0 | In-house |
2.Estrogens | |||
1 | Estrone | 53-16-7 | USP42 |
2 | β-estradiol | 50-28-2 | USP42 |
3 | Estriol | 50-27-1 | USP42,EP8.0 |
4 | Estradiol Cypionate | 313-06-4 | USP42 |
5 | Estradiol Valerate | 979-32-8 | USP42 |
6 | Estradiol Benzoate | 50-50-0 | USP42,EP9.0 |
7 | Estradiol Enanthate | 4956-37-0 | In-house |
8 | Estradiol Benzoate Butyrate | 63042-18-2 | In-house |
9 | Estradiol Dipropionate | 113-38-2 | In-house |
10 | 2-Methoxyestradiol | 362-07-2 | In-house |
11 | β-Estradiol 17-acetate | 1743-60-8 | In-house |
3.Intermediates | |||
1 | 17a-hydroxyprogesterone | 68-96-2 | In-house |
2 | 17a-hydroxyprogesterone Acetate | 302-23-8 | In-house |
3 | 17-Hydroxy-6-Methylenepregn-4-Ene-3 | 32634-95-0 | In-house |
4 | Pregnenolone | 145-13-1 | In-house |
5 | Pregnenolone Acetate | 1778-02-5 | In-house |
7 | 6-Dehydroprogesterone | 1162-56-7 | In-house |
10 | 6-Ketoprogesterone | 2243-08-5 | In-house |
12 | Dihydroproscar | 98319-24-5 | In-house |
13 | / | 166896-74-8 | In-house |
18 | acetate | 853-23-6 | In-house |
22 | Estradiene Dione-3-Keta | 5571-36-8 | In-house |
4.Anti-Cancer Drug | |||
2 | Finasteride | 98319-26-7 | USP39 |